Pure Global AI
NCT06313710Not yet recruiting

Head Down Position for Successful Recanalization of Anterior Circulation Large Vessel Occlusion (HOPES4)

Head Down Position for Successful Recanalization of Anterior Circulation Large Vessel Occlusion (HOPES3): a Prospective, Randomized, Open Label, Blinded-end Point, Single-center Study
General Hospital of Shenyang Military RegionClinicalTrials.govother
Verified
Study focus
Disease/Condition
Ischemic Stroke
Drug/Device/Intervention
head down position
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
General Hospital of Shenyang Military Region
Location
Shenyang, China
Timeline & enrollment
Phase
N/A
Start date
May 10, 2024
End date
Dec 01, 2026
Enrollment
90 participants
Primary outcome

Changes in National Institute of Health stroke scale (NIHSS)

Summary

This is a prospective, randomized, open label, blinded-end point, single-center study, aiming
 to investigate the effect of head down position in anterior circulation large vessel
 occlusion patients with successful recanalization after endovascular treatment.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionCerebral infarction, unspecifiedOther cerebral infarction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06313710
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06313710 through Pure Global AI's free database. This phase not specified trial is sponsored by General Hospital of Shenyang Military Region and is currently Not yet recruiting. The study focuses on Ischemic Stroke. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.